David Trent

4.6k citations
27 papers · 3.8k · 3 hit papers · h-index 19

Impact in

    • Venous Thromboembolism Diagnosis and Management
  • Oncology top 2%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies

Papers in

David Trent

27 papers receiving 3.7k citations

Hit Papers

Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2015 · 695 citations
6950+6+12Years since publication250500750

Peers

David Trent
Comparison fields: 5 of 120
  • Internal Medicine 630
  • Oncology 1.5k
  • Pulmonary and Respiratory Medicine 1.5k
  • Emergency Medical Services 255
  • Endocrinology, Diabetes and Metabolism 454
Replace Leo R. Zacharski with:
Leo R. Zacharski United States
James R. Rigas United States
Tom R. Fitch United States
F. Lofts United Kingdom
David D. Stenehjem United States
D C Tormey United States
Albert Abad Spain
Roscoe F. Morton United States
Frederick R. Ahmann United States
Roger Keresztes United States
David Trent relative to Leo R. Zacharski United States Leo R. Zacharski's profile →
Citations per field
00.5×4.8×
Leo R. Zacharski · 1×
Citations per year

Countries citing papers authored by David Trent

Since Specialization
Citations

This map shows the geographic impact of David Trent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Trent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Trent more than expected).

Fields of papers citing papers by David Trent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Trent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Trent. The network helps show where David Trent may publish in the future.

Co-authors

The 25 scholars most cited alongside David Trent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Trent Line = papers co-authored together David Trent links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
Hit paper breakdown →
2009752
2
American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer
Hit paper breakdown →
2007723
3
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Hit paper breakdown →
2015695
4 1983379
5 1981273
6 2011234
7
The selective antiproliferative effects of alpha-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds.
1994121
8 201372
9 201062
10 198159
11 198955
12 201048
13 198439
14 200934
15 200734
16 198131
17 197927
18 199122
19 200719
20 201112

About David Trent

David Trent is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Endocrinology, Diabetes and Metabolism, having authored 27 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Pancreatic function and diabetes (5 papers), Diabetes and associated disorders (4 papers), Lung Cancer Research Studies (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Folate and B Vitamins Research (4 papers), Biochemical and Molecular Research (3 papers) and Neuroendocrine Tumor Research Advances (3 papers). The work is most often cited by research in Internal Medicine (630 citations), Oncology (1.5k citations), Pulmonary and Respiratory Medicine (1.5k citations), Emergency Medical Services (255 citations) and Endocrinology, Diabetes and Metabolism (454 citations). David Trent has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Gordon C. Weir, Susan Bonner‐Weir, Thomas J. Smith, John R. Strawn, Julie R. Brahmer, Joan H. Schiller, Gregory A. Masters, Sherman Baker, Giuseppe Giaccone and Christopher G. Azzoli. Their work appears in journals such as Journal of Clinical Oncology, Journal of Biological Chemistry, Endocrinology, Diabetes and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact